Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -0.0% | -3.7% | 1 / 3 | +2.8% | -0.85 pp | -0.17 pp | -48.5% | -6.10 | 5.19 | 72,0 | +2,8% | 2,8 | −1,6% | 5.19 | -6.28 | — |
| Pts | 0 | 0 | 4 | 0 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 3.000 (close price on 2026-01-30)EPS (TTM): 577,7
Financial charts
1.Revenue & growth
VND bn72,0Q2/26
1.Revenue & growth
VND bn72,0Q2/26
2.Profit & growth
VND bn2,27Q2/26
3.Profit mix (Penman)
VND bn21,5Q2/26
4.Margins & cost structure
%19.0%Q2/26
5.Returns & cash cycle
% · days24.9%Q2/26
6.Earnings quality & cash
VND bn9,50Q2/26
7.Asset structure
VND bn821Q2/26
8.Funding & debt health
VND bn · times821Q2/26
9.Revenue backlog
VND bn193Q2/26
10.Valuation
times · %5,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %95Q2/26
Adjusted EPS growth, latest quarter
-0.0%
Average adjusted EPS growth, 3 quarters
-3.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26